Skip to main content
. Author manuscript; available in PMC: 2023 Jul 27.
Published in final edited form as: NeuroImmune Pharm Ther. 2022 Aug 15;2(2):95–101. doi: 10.1515/nipt-2022-0010

Table 1.

Participant Characteristics (Number, Mean± Standard Deviation or range)

PASC, n=30 Controls, n=27 P Value
Men / Women 10 / 20 11 / 16 0.56a
Age (Years, range) 42.7 ± 12.2 (21–63) 43.8 ± 12.2 (25–68) 0.73b
Body Mass Index 31.4 ± 8.8 28.0 ± 7.5 0.12b
Index of Social Position d 30.4 ± 13.8 28.9 ± 14.0 0.69b
Education
Graduate / Undergraduate / Some College / High School 8 / 9 / 8 / 5 13 / 8 / 3 / 3 0.28a
Race/Ethnicity
White / Hispanic / Asian / Black / Biracial 19 / 1 / 0 / 9 / 1 9 / 4 / 2 / 12 / 0 0.07a
History of Substance Use
Past Month Alcohol 24 22 0.95a
Lifetime Alcohol 24 22 0.95a
Past Month Tobacco 1 1 1c
Lifetime Tobacco 10 10 1a
Past Month Marijuana e 4 2 0.67c
Lifetime Marijuana 15 6 0.03 a
Comorbid Risk Factors for COVID-19
Hypertension 6 4 0.26c
Diabetes 4 0 0.11c
Overweight / Obese 9 / 14 6 / 9 0.96a
COPD f 5 0 0.05c

Participants were recruited from the local community using online advertisements (Craigslist, Facebook Long-COVID support groups), flyers, word of mouth, and referrals from healthcare providers and post-COVID clinics. Phone screens were completed for 169 participants. Of those, 61 provided written informed consent and completed the in-person screening visit. Three were no longer eligible after the screening visit and one declined to continue participating. Inclusion criteria: 1) adults between 18–75 years; 2) ability to provide informed consent; 3) documented diagnosis of COVID-19 >6 weeks ago OR no history of COVID-19 with a negative antigen test at the screening visit. Exclusion criteria: 1) any confounding neurological, psychiatric, or medical disorders; 2) any current/past severe substance use disorder (Diagnostic and Statistical Manual of Mental Disorders 5), except for tobacco/cannabis; 3) pregnancy/breast-feeding. All participants underwent a structured medical history, physical/neurological examination, and urine toxicology screening. All provided written informed consent and the protocol was approved by the University of Maryland, Baltimore Institutional Review Board. Demographic data were compared between groups using a Chi-Square test, b T-Test, or c Fisher’s Exact Test-tests as appropriate. d Index of Social Position (ISP) was calculated using the Hollingshead Four Factor Index of Socioeconomic Status (4) e Includes two PASC that used cannabidiol. f Chronic Obstructive Pulmonary Disease